Published in Metabolism on March 01, 1970
Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones, and cholestasis. J Clin Invest (1971) 1.97
Hepatic organic anion uptake in the rat. J Clin Invest (1975) 1.49
Graft-versus-leukemia reactions after bone marrow transplantation. Blood (1990) 7.11
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82
Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology (1968) 3.23
Vitamin D deficiency inhibits pancreatic secretion of insulin. Science (1980) 3.00
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. Blood (1994) 2.78
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest (1984) 2.52
Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood (1990) 2.42
Cation requirements for insulin secretion in the isolated perfused pancreas. Diabetes (1966) 2.21
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest (1972) 2.20
Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases. Vox Sang (1992) 2.05
The response of human leucocyte cultures to stimulation by tuberculin and phytohaemagglutinin measured by the uptake of radioactive thymidine. Clin Exp Immunol (1967) 2.01
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood (1990) 1.98
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med (1997) 1.93
Requirement for calcium ion in insulin secretion by the perfused rat pancreas. Am J Physiol (1968) 1.82
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet (2001) 1.76
Safety of retroviral gene marking with a truncated NGF receptor. Nat Med (2003) 1.60
Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res (2001) 1.60
The in vitro perfused pancreas. Methods Enzymol (1975) 1.56
Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest (1974) 1.55
Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1(low), c-kit+ stem cell line. J Hematother Stem Cell Res (1999) 1.51
Insulin secretion. Interrelationships of glucose, cyclic adenosine 3:5-monophosphate, and calcium. J Biol Chem (1975) 1.50
Effect of selected hexoses, of epinephrine and of glucagon on insulin secretion in man. Diabetes (1966) 1.48
Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler (1986) 1.45
Adenosine 3',5'-monophosphate in pancreatic islets: glucose-induced insulin release. Science (1973) 1.43
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med (1997) 1.41
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol (1996) 1.40
Late effects of transplantation. Gerard Socie, for the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Lancet (1999) 1.39
Immunologic studies of adrenocorticotropic hormone (ACTH): dissociation of biologic and immunologic activities. J Clin Endocrinol Metab (1965) 1.38
Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes (1980) 1.29
Isolation of mitochondrial succinate: ubiquinone reductase, cytochrome c reductase and cytochrome c oxidase from Neurospora crassa using nonionic detergent. Eur J Biochem (1979) 1.28
Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology (1999) 1.27
Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant (1996) 1.24
Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases. Br J Haematol (1988) 1.23
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant (1991) 1.23
Renal complications in acute leukemias. Haematologica (1998) 1.23
Regulation of pancreatic insulin and glucagon secretion. Annu Rev Physiol (1976) 1.23
Stimulation of insulin release by glucagon in noninsulin-dependent diabetics. Metabolism (1966) 1.17
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. Blood (1993) 1.16
A threshold distribution hypothesis for packet storage of insulin. II. Effect of calcium. Diabetes (1972) 1.14
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant (2000) 1.14
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol (1999) 1.13
Expression of the insulin-like growth factor-II/mannose-6-phosphate receptor in multiple human tissues during fetal life and early infancy. J Clin Endocrinol Metab (1992) 1.12
Pancreatic action of the sulfonylureas. Fed Proc (1977) 1.11
The relationship of obesity and growth hormone to serum insulin levels. Ann N Y Acad Sci (1965) 1.09
Insulin and the pancreas. Annu Rev Physiol (1966) 1.08
[Further studies on the dynamic aspects of insulin release in vitro with evidence for a two-compartmental storage system]. Acta Diabetol Lat (1969) 1.08
Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood (1997) 1.07
Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation. Transplant Proc (1993) 1.07
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1998) 1.07
[Allogeneic transplantation in malignant lymphoma]. Dtsch Med Wochenschr (2001) 1.06
Inhibition by somatostatin of glucagon and insulin release from the perfused rat pancreas in response to arginine, isoproterenol and theophylline: evidence for a preferential effect on glucagon secretion. Endocrinology (1975) 1.06
Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics. Stem Cells (2000) 1.06
Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol (2000) 1.05
Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology (2001) 1.05
Dynamic synthesis and release of insulin and proinsulin from perifused islets. Diabetes (1973) 1.05
Early phase of insulin release. Diabetes (1968) 1.04
Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. Transplant Proc (1981) 1.03
Evidence that glucose "marks" beta cells resulting in preferential release of newly synthesized insulin. Science (1982) 1.02
Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients. Antimicrob Agents Chemother (1997) 1.01
Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res (2000) 1.00
The third phase of in vitro insulin secretion. Evidence for glucose insensitivity. Diabetes (1986) 0.99
Relationships between arginine and glucose in the induction of insulin secretion from the isolated, perfused rat pancreas. Endocrinology (1972) 0.99
Diabetes mellitus in rabbits immunized with insulin. Diabetes (1966) 0.98
Marrow grafts between DL-A-matched canine littermates. Transplantation (1973) 0.97
Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group. Clin Infect Dis (1992) 0.97
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia (2002) 0.96
Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells. Int J Cancer (1996) 0.96
Effect of pulse administration of glucose or glucagon on insulin secretion in vitro. Metabolism (1967) 0.95
Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. J Immunol (1974) 0.95
Abnormal secretion of insulin and glucagon by the in vitro perfused pancreas of the genetically diabetic Chinese hamster. J Clin Invest (1974) 0.95
Insulin and the pancreas. Vitam Horm (1970) 0.95
[Factors influencing different rates of insulin release in vitro]. Acta Diabetol Lat (1968) 0.94
Glucose-stimulated 45Calcium efflux from isolated rat pancreatic islets. J Clin Invest (1978) 0.94
Experimental immune diabetes in the rabbit. Light, fluorescence, and electron microscopic studies. Am J Pathol (1969) 0.94
Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus. Diabetes Res (1991) 0.94
Characteristics of desensitization of insulin secretion in fully in vitro systems. Endocrinology (1988) 0.94
The clinical-chemical screen in the Munich ENU Mouse Mutagenesis Project: screening for clinically relevant phenotypes. Mamm Genome (2000) 0.94
Prevention of insulin aggregation by dicarboxylic amino acids during prolonged infusion. Diabetes (1981) 0.93
Characterization of the active site, substrate specificity and kinetic properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver. Biochim Biophys Acta (1983) 0.93
Cyclic nucleotides in pancreatic islets. Tolbutamide- and arginine-induced insulin release. Diabetes (1976) 0.92
Constitutively active stimulatory G-protein alpha s in beta-cells of transgenic mice causes counterregulation of the increased adenosine 3',5'-monophosphate and insulin secretion. Endocrinology (1994) 0.92
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study. Transplantation (1995) 0.92
Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol (1996) 0.92
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood (1989) 0.92
Contrasting patterns of insulin biosynthesis, compartmental storage, and secretion. Rat tumor versus islet cells. Diabetes (1984) 0.92
2,3-Diphosphoglycerate fluctuations in erythrocytes reflecting pronounced blood glucose variation. In-vivo and in-vitro studies in normal, diabetic and hypoglycaemic subjects. Diabetologia (1973) 0.92
Angiitis of the central nervous system after allogeneic bone marrow transplantation? Stroke (1999) 0.92
Comparison of storage- and signal-limited models of pancreatic insulin secretion. Am J Physiol (1980) 0.92
Muscle triglycerides in diabetic subjects. Effect of insulin deficiency and exercise. Diabetologia (1980) 0.91
Anomeric specificity of glucose-stimulated insulin release: evidence for a glucoreceptor? Science (1974) 0.91
Measurement of immune complexes in insulin-treated diabetics. J Immunol Methods (1973) 0.90